| Financial Year |
March 31 2022 |
| Monetary Funds |
193,927,232.89 |
| Held-for-trading Financial Assets |
75,561.33 |
| Notes Receivable |
161,259,610.31 |
| Accounts Receivable |
284,549,011.43 |
| Advances to Suppliers |
7,530,737.15 |
| Other Receivables |
4,607,080.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
172,427,133.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,806,300.64 |
| Total Current Assets |
1,005,547,392.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
12,671,055.03 |
| Fixed Assetes |
137,159,711.22 |
| Under-construction Projects |
3,725,402.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,109,278.19 |
| R&D expenses |
3,072,349.03 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
124,772.95 |
| Deferred Income Tax Assets |
18,481,269.62 |
| Other Non-Current Assets |
5,760,392.34 |
| Sub-Total of Non-Current Assets |
241,739,092.39 |
| Total Assets |
1,247,286,485.12 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
161,194,146.44 |
| Accounts Payable |
252,630,512.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,719,772.32 |
| Taxes Payable |
5,942,955.89 |
| Interest Payable |
-- |
| Dividend Payable |
4,749,548.04 |
| Other payables |
44,319,427.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,341,037.13 |
| Other Current Liabilities |
28,989,921.20 |
| Sub-Total of Current Liabilities |
514,276,102.71 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
23,892,738.70 |
| Deferred Income Tax Liabilities |
273,474.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
89,908,289.31 |
| Total Liabilities |
604,184,392.03 |
| Paid-In Capital(Or Share Stock) |
141,516,450.00 |
| Capital Surplus |
89,117,475.01 |
| Surplus Reserve |
36,614,479.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
220,169,729.62 |
| Minority Stockholder's Interest |
147,595,728.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
495,506,364.25 |
| Owner's Equity（Stockholder's Equity） |
643,102,093.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,247,286,485.12 |
